Abstract
Background: Complementary and alternative medicine (CAM) in psychiatry or integrative psychiatry covers a wide range of biological, psychological and mind-body treatments that enhance standard medical practices and patient outcomes. While CAM approaches are popular among patients, health professionals have received limited education in these interventions and they are often unaware of their patients’ use of CAM treatments.
Method: This overview highlights evidence-based CAM treatments for attention deficit hyperactivity disorder (ADHD) including dietary interventions, phytomedicines, mind-body practices and neurofeedback.
Results: While conventional treatments are the mainstays for ADHD, there are a large number of available treatments that can be used to enhance treatment response.
Conclusion: With improved education and further scientific and clinical research, validated integrative treatments will provide more effective, lower risk and lower cost care for patients with ADHD.
Keywords: Complementary and alternative medicine, ADHD, diet, herbs, melatonin, nootrophics, yoga, breathing practices, meditation, neurofeedback.
Adolescent Psychiatry
Title:Non-Pharmacological Treatments for ADHD in Youth
Volume: 5 Issue: 2
Author(s): Anup Sharma, Patricia L. Gerbarg and Richard P. Brown
Affiliation:
Keywords: Complementary and alternative medicine, ADHD, diet, herbs, melatonin, nootrophics, yoga, breathing practices, meditation, neurofeedback.
Abstract: Background: Complementary and alternative medicine (CAM) in psychiatry or integrative psychiatry covers a wide range of biological, psychological and mind-body treatments that enhance standard medical practices and patient outcomes. While CAM approaches are popular among patients, health professionals have received limited education in these interventions and they are often unaware of their patients’ use of CAM treatments.
Method: This overview highlights evidence-based CAM treatments for attention deficit hyperactivity disorder (ADHD) including dietary interventions, phytomedicines, mind-body practices and neurofeedback.
Results: While conventional treatments are the mainstays for ADHD, there are a large number of available treatments that can be used to enhance treatment response.
Conclusion: With improved education and further scientific and clinical research, validated integrative treatments will provide more effective, lower risk and lower cost care for patients with ADHD.
Export Options
About this article
Cite this article as:
Sharma Anup, L. Gerbarg Patricia and P. Brown Richard, Non-Pharmacological Treatments for ADHD in Youth, Adolescent Psychiatry 2015; 5 (2) . https://dx.doi.org/10.2174/221067660502150430154937
DOI https://dx.doi.org/10.2174/221067660502150430154937 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Commentary [Research Highlights (Making Sense Out of Antisense in Huntington’s Disease)]
CNS & Neurological Disorders - Drug Targets Editorial (Thematic Issue: Linkage of Neurodegenerative Disorders with Other Health Issues – Volume I)
CNS & Neurological Disorders - Drug Targets Melatonin, a Potential Therapeutic Agent for Smooth Muscle-Related Pathological Conditions and Aging
Current Medicinal Chemistry Interaction of Steroids with the GABA-A Receptor
Current Topics in Medicinal Chemistry Recent Advances in MRI Based Volumetry and Morphometry for AD Diagnosis in Human
Current Medical Imaging Involvement of the Blood-Brain Barrier in Metabolic Regulation
CNS & Neurological Disorders - Drug Targets 2, 5-Disubstituted Phthalimides: Design, Synthesis and Anticonvulsant Activity in scPTZ and MES Models
Current Computer-Aided Drug Design Antipsychotic and Antiepileptic Drugs in Bipolar Disorder: The Importance of Therapeutic Drug Monitoring
Current Medicinal Chemistry New Glycoside Esters from the Aerial Parts of Artemisia absinthium Linn.
The Natural Products Journal HLA and TCR Recognition of Medications in Severe Cutaneous Adverse Reactions
Current Immunology Reviews (Discontinued) ABC Transporters: Unvalidated Therapeutic Targets in Cancer and the CNS
Anti-Cancer Agents in Medicinal Chemistry From Cannabis to Cannabidiol to Treat Epilepsy, Where Are We?
Current Pharmaceutical Design Role of Nitric Oxide and Calpain Activation in Neuronal Death and Survival
Current Drug Targets - CNS & Neurological Disorders Chvostek's Sign in Paediatric Practice
Current Pediatric Reviews Novel Neuroendocrine and Metabolic Mechanism Provides the Patented Platform for Important Rejuvenation Therapies: Targeted Therapy of Telomere Attrition and Lifestyle Changes of Telomerase Activity with the Timing of Neuron-Specific Imidazole-Containing Dipeptide-Dominant Pharmaconutrition Provision
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery High-throughput Genotyping Methods for Pharmacogenomic Studies
Current Pharmacogenomics Inflammation and Epilepsy: Preclinical Findings and Potential Clinical Translation
Current Pharmaceutical Design Recent Advancement in the Field of Anticonvulsants: A Review
Letters in Drug Design & Discovery Synthesis and Evaluation of the Anticonvulsant Activities of New 5-substitued-[1,2,4]triazolo[4,3-a]quinoxalin-4(5H)-one Derivatives
Letters in Drug Design & Discovery Immunotoxins Constructed with Ribosome-Inactivating Proteins and their Enhancers: A Lethal Cocktail with Tumor Specific Efficacy
Current Pharmaceutical Design